We had a discussion about a new theory related to gravity and how could it be shaping our guts, minds and stomachs. Dr. Brennan Spiegel was joined by Dr. Megan Riehl, PsyD and Kate Scarlata, MPH, RDN to unravel if gravity could actually be shaping our guts, minds and stomachs and might IBS be a symptom of this dysregulation.

This Tuesday Night IBS webinar features Dr. Kyle Staller an adult gastroenterologist, and Dr. Thomas Wallach a pediatric gastroenterologist. They both discuss how to manage IBS-C in adults and children and whether you should discuss new treatments with your own doctor.

Listen to our 2025 webinar with Dr. Mark Pimentel of MAST at Cedars-Sinai. Dr. Pimentel discusses the newest research on SIBO, IBS and present mock case studies.Mark Pimentel, MD, is the executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai and in collaboration with Ruchi Mathur, MD, whose work focuses on links between metabolic disease and gut microbiome, and Ali Rezaie, MD, whose innovative work in GI motility improves the wellbeing of patients, as part of the MAST team they focus on the development of drugs, diagnostic tests and devices related to conditions of the microbiome. - Pimentel Lab

In this special crossover podcast episode, Tuesday Night IBS co-hosts Jeffrey Roberts MSEd BSc and Erica Dermer are joined live by Dr. William Chey, Amanda Lynett MS RDN and Kate Scarlata MPH RDN at FOOD The Main Course in Ann Arbor, MI. This episode discusses the following topics:The evolution of FOOD: The Main Course over the years and why dietitians should attendThe role and benefit of incorporating GI dietitians into integrated care modelsThe evolution of GI dietitians at major GI meetings like DDWIBS, your diet and the microbiomeStress, your diet and IBSGLP-1 use and increased GI symptomsCombating GI misinformation onlineOstomies for severe constipation?Check out even more episodes at Healio's Gut Talk Podcast website and submit comments and questions to guttalkpodcast@healio.com. Check out Tuesday Night IBS for more evidence-based webinars and podcasts at TuesdayNightIBS.com.

In this special crossover podcast episode, Tuesday Night IBS host Jeffrey Roberts, MSEd, BSc, and Kate Scarlata, MPH, RDN, are joined live by William Chey, MD, and Amanda Lynett, MS, RDN, at FOOD the Main Course Conference in Ann Arbor, MI.Amanda Lynett MS, RDN, is a registered dietitian with her masters. Amanda is with the Division of Gastroenterology at Michigan Medical in Ann Arbor.Jeffrey Roberts, MSEd, BSc, is a patient advocate and creator of the first website for IBS sufferers. He is the co-founder of Tuesday Night IBS.Kate Scarlata, MPH, RDN, is a US-based dietitian with over 30 years of experience. Kate’s expertise is in gastrointestinal disorders and food intolerance.We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow uson X @HealioGastro @sameerkberry @umfoodoc. For more Tuesday Night IBS, be sure check out TuesdayNightIBS.com and to follow and subscribe to their podcast.Disclosures: Chey and Roberts report no relevant financial disclosures. Scarlata reports stock options with Epicured LLC and FODY Food Company, financial support from Dr. Schar, Mahana Therapeutics, Nestle Health Science, Olipop, Pendulum, QOL Medical.

On this special episode of Tuesday Night IBS, we talk with the co-principal investigator, Alex Ford, MD, from Leeds University in the UK, about the ATLANTIS trial of Amitriptyline for irritable bowel syndrome (IBS) in primary care, which was funded by the Health Technology Assessment program of the National Institute for Health and Care Research and the TRITON trial using Ondansetron to manage irritable bowel syndrome with diarrhea.Dr. Alex Ford is a Professor and Honorary consultant gastroenterologist at St. James’s University Hospital, Leeds, UK. His main interest is in the epidemiology, diagnosis, and treatment of disorders of gut-brain interaction, such as irritable bowel syndrome and functional dyspepsia. He is an Associate Editor for Alimentary Pharmacology & Therapeutics. He has published over 450 peer-reviewed articles, including original scientific papers in The Lancet, JAMA, BMJ, Gastroenterology, Gut, Archives of Internal Medicine, and The American Journal of Gastroenterology.

Join us as experts Dr. Anthony Lembo and Dr. Lin Chang, discuss the future of IBS management with more precise testing and tailored treatments and the benefits of a new diagnostic test for IBS, InFoods IBS.

Join an expert panel and a patient living with IBS-C as we deep dive into real-life patient cases, discuss evidence-based strategies to diagnose patients with IBS-C from a biopsychosocial approach, and use shared decision-making to help patients regain control of their lives and improve patient and provider satisfaction. Featuring Christina Hanson, FNP-C, Kimberly Kearns, APRN, ANP-BC, and Suzanne, a patient with IBS-C.

Jeffrey Roberts and Johannah Ruddy talk with registered GI dietitian Taylor Hanna from Diet vs. Disease about SIBO and how it differs from IBS but can occur concurrently. How common is it, how is it treated, and how can diet therapy help patients keep symptoms related to SIBO from returning? Don’t miss this special episode.

Join Tuesday Night IBS and our friends at Diet vs Disease as we feature Kate Scarlata, RD and William Chey, MD to discuss this important topic of SIBO and IBS. We will hear from both presenters about SIBO, what it is, how to treat and prevent it, and how good access to dietitians and other HCP can improve health outcomes.

Kate Scarlata RD, MPH, discusses how a multi-disciplinary approach to IBS management can benefit symptoms and improve quality of life.

Dr. Megan E. Riehl, discusses IBS myths in symptoms and treatments, as well as IBS mimickers that need to be considered in the diagnostic process.

Darren Brenner, MD outlines the testing recommendations when looking at an IBS diagnosis based on sub-type. #WorldIBSDay2023

Did you know #IBS-C is the most commonly diagnosed Disorder of Gut Brain Interaction (DGBI) with a high level of illness burden & decreased QoL? Let's start treating #IBS-C w/the tools we have available! Hear more about the new and novel therapy available as well as simple lifestyle changes that can improve symptoms. Dr. Philip Schoenfeld and Dr. Megan Riehl discuss Tenapanor for medical management, relaxation and breathing tips before and during a bowel movement and Suzanne, IBS patient advocate shares her powerful story of illness and relief.

Johannah is joined by guests Simon Levy the CEO and Founder of Mahana, Dr. Emeran Mayer renowned Gastroenterologist who specializes in Brain-Gut-Microbiome and Diane Chung a patient advocate. The discussion centers around the overlap of IBS with IBD and the guests go into detail about CBT's.

We get to the bottom of Gut Directed Hypnotherapy for IBS management and the efficacy of its therapeutic properties. We also explore the growing world of digital therapeutics that are expanding access to these therapies, such as Regulora, FDA cleared digital app for GDH in IBS.

This month we welcome Wendy Busse, RD who specializes in working with patients who have developed a conditioned food sensitivity due to a foodrelated trauma or from negative food related GI symptoms. What are the best ways to manage this type of dietary over-restriction issue and how can patients and providers work together to get back to a healthy relationship with food? Join us to find out.Learn more: https://fastfreedomprogram.com/

In this new episode we talk with Philip Schoenfeld MD @EBGIdoc & Jill Deutsch MD about their review article: "Treating All the Symptoms of IBS-C: a review of the data on Linaclotide" We break down the role for Secretagogues in IBS-C management, the efficacy data on pain reduction as well as normalization of bowel habit and how this relates to everyday patient care. It's a great discussion that you will not want to miss!

In this episode for August, we talk with well respected psychologist Dr Olafur Palsson from the University of North Carolina, Chapel Hill about the well founded data to support the use of gut directed hypnosis (GDH) in the management of IBS. We also talk with Tim Rudolphi, CEO of metaMe Health about the new digital therapeutic Regulora, approved by the FDA for management of IBS and how digital therapies are changing the game for patients with IBS.

This special episode features the live Grand Rounds presentation from our friends at the Rome Foundation with guest experts Dr. Douglas Drossman, Dr. Lin Chang, and Dr Brian Lacy. A special thank you to the Rome Foundation for their collaboration and for allowing us highlight this session on our podcast this month. See more about the guidelines on our website: www.tuesdaynightibs.comSpecial thank you to Abbive US for supporting the July programming on Tuesday Night IBS.